Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
Chronic infections are an increasing problem due to the aging population and the increase in antibiotic resistant organisms. Therefore, understanding the host-pathogen interactions that result in chronic infection is of great importance. Here, we investigate the molecular basis of chronic bacterial cystitis. We establish that introduction of uropathogenic E. coli (UPEC) into the bladders of C3H mice results in two distinct disease outcomes: resolution of acute infection or development of chronic cystitis lasting months. The incidence of chronic cystitis is both host strain and infectious dose-dependent. Further, development of chronic cystitis is preceded by biomarkers of local and systemic acute inflammation at 24 hours post-infection, including severe pyuria and bladder inflammation with mucosal injury, and a distinct serum cytokine signature consisting of elevated IL-5, IL-6, G-CSF, and the IL-8 analog KC. Mice deficient in TLR4 signaling or lymphocytes lack these innate responses and are resistant, to varying degrees, to developing chronic cystitis. Treatment of C3H mice with the glucocorticoid anti-inflammatory drug dexamethasone prior to UPEC infection also suppresses the development of chronic cystitis. Finally, individuals with a history of chronic cystitis, lasting at least 14 days, are significantly more susceptible to redeveloping severe, chronic cystitis upon bacterial challenge. Thus, we have discovered that the development of chronic cystitis in C3H mice by UPEC is facilitated by severe acute inflammatory responses early in infection, which subsequently are predisposing to recurrent cystitis, an insidious problem in women. Overall, these results have significant implications for our understanding of how early host-pathogen interactions at the mucosal surface determines the fate of disease.
Vyšlo v časopise:
Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001042
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001042
Souhrn
Chronic infections are an increasing problem due to the aging population and the increase in antibiotic resistant organisms. Therefore, understanding the host-pathogen interactions that result in chronic infection is of great importance. Here, we investigate the molecular basis of chronic bacterial cystitis. We establish that introduction of uropathogenic E. coli (UPEC) into the bladders of C3H mice results in two distinct disease outcomes: resolution of acute infection or development of chronic cystitis lasting months. The incidence of chronic cystitis is both host strain and infectious dose-dependent. Further, development of chronic cystitis is preceded by biomarkers of local and systemic acute inflammation at 24 hours post-infection, including severe pyuria and bladder inflammation with mucosal injury, and a distinct serum cytokine signature consisting of elevated IL-5, IL-6, G-CSF, and the IL-8 analog KC. Mice deficient in TLR4 signaling or lymphocytes lack these innate responses and are resistant, to varying degrees, to developing chronic cystitis. Treatment of C3H mice with the glucocorticoid anti-inflammatory drug dexamethasone prior to UPEC infection also suppresses the development of chronic cystitis. Finally, individuals with a history of chronic cystitis, lasting at least 14 days, are significantly more susceptible to redeveloping severe, chronic cystitis upon bacterial challenge. Thus, we have discovered that the development of chronic cystitis in C3H mice by UPEC is facilitated by severe acute inflammatory responses early in infection, which subsequently are predisposing to recurrent cystitis, an insidious problem in women. Overall, these results have significant implications for our understanding of how early host-pathogen interactions at the mucosal surface determines the fate of disease.
Zdroje
1. AriasCa
MurrayBe
2009 Antibiotic-Resistant Bugs In The 21st Century–A Clinical Super-Challenge. N Engl J Med 360 439 443
2. KimEy
BattaileJt
PatelAc
YouY
AgapovE
2008 Persistent Activation Of An Innate Immune Response Translates Respiratory Viral Infection Into Chronic Lung Disease. Nat Med 14 633 640
3. CassellGh
1998 Infectious Causes Of Chronic Inflammatory Diseases And Cancer. Emerg Infect Dis 4 475 487
4. MonackDm
MuellerA
FalkowS
2004 Persistent Bacterial Infections: The Interface Of The Pathogen And The Host Immune System. Nat Rev Microbiol 2 747 765
5. NickelJc
2005 Management Of Urinary Tract Infections: Historical Perspective And Current Strategies: Part 1–Before Antibiotics. J Urol 173 21 26
6. GrieblingTl
2007 Urinary Tract Infection In Women.
LitwinMs
SaigalCs
Urologic Diseases In America Us Dhhs, Phs, Nih, Niddk Washington, Dc Us Gpo 587 620
7. FoxmanB
2002 Epidemiology Of Urinary Tract Infections: Incidence, Morbidity, And Economic Costs. American Journal Of Medicine 113 Suppl 1a 5s 13s
8. LangermannS
MollbyR
BurleinJe
PalaszynskiSr
AugusteCg
2000 Vaccination With Fimh Adhesin Protects Cynomolgus Monkeys From Colonization And Infection By Uropathogenic Escherichia Coli. J Infect Dis 181 774 778
9. ThumbikatP
WaltenbaughC
SchaefferAj
KlumppDj
2006 Antigen-Specific Responses Accelerate Bacterial Clearance In The Bladder. J Immunol 176 3080 3086
10. HopkinsWj
ElkahwajiJ
BeierleLm
LeversonGe
UehlingDt
2007 Vaginal Mucosal Vaccine For Recurrent Urinary Tract Infections In Women: Results Of A Phase 2 Clinical Trial. J Urol 177 1349 1353 Quiz 1591
11. HopkinsWj
UehlingDt
WargowskiDs
1999 Evaluation Of A Familial Predisposition To Recurrent Urinary Tract Infections In Women. Am J Med Genet 83 422 424
12. ScholesD
HootonTm
RobertsPl
StapletonAe
GuptaK
2000 Risk Factors For Recurrent Urinary Tract Infection In Young Women. J Infect Dis 182 1177 1182
13. GuptaK
HootonTm
StammWe
2001 Increasing Antimicrobial Resistance And The Management Of Uncomplicated Community-Acquired Urinary Tract Infections. Ann Intern Med 135 41 50
14. RazR
ChazanB
KennesY
ColodnerR
RottensterichE
2002 Empiric Use Of Trimethoprim-Sulfamethoxazole (Tmp-Smx) In The Treatment Of Women With Uncomplicated Urinary Tract Infections, In A Geographical Area With A High Prevalence Of Tmp-Smx-Resistant Uropathogens. Clin Infect Dis 34 1165 1169
15. RonaldA
2002 The Etiology Of Urinary Tract Infection: Traditional And Emerging Pathogens. American Journal Of Medicine 113 Suppl 1a 14s 19s
16. MartinezJj
MulveyMa
SchillingJd
PinknerJs
HultgrenSj
2000 Type 1 Pilus-Mediated Bacterial Invasion Of Bladder Epithelial Cells. Embo Journal 19 2803 2812
17. MulveyMa
Lopez-BoadoYs
WilsonCl
RothR
ParksWc
1998 Induction And Evasion Of Host Defenses By Type 1-Piliated Uropathogenic Escherichia Coli. Science 282 1494 1497
18. DuncanMj
LiG
ShinJs
CarsonJl
AbrahamSn
2004 Bacterial Penetration Of Bladder Epithelium Through Lipid Rafts. Journal Of Biological Chemistry 279 18944 18951
19. MartinezJj
HultgrenSj
2002 Requirement Of Rho-Family Gtpases In The Invasion Of Type 1-Piliated Uropathogenic Escherichia Coli. Cellular Microbiology 4 19 28
20. SongJ
BishopBl
LiG
DuncanMj
AbrahamSn
2007 Tlr4-Initiated And Camp-Mediated Abrogation Of Bacterial Invasion Of The Bladder. Cell Host Microbe 1 287 298
21. DhakalBk
MulveyMa
2009 Uropathogenic Escherichia Coli Invades Host Cells Via An Hdac6-Modulated Microtubule-Dependent Pathway. J Biol Chem 284 446 454
22. BishopBl
DuncanMj
SongJ
LiG
ZaasD
2007 Cyclic Amp-Regulated Exocytosis Of Escherichia Coli From Infected Bladder Epithelial Cells. Nat Med 13 625 630
23. AndersonGg
PalermoJj
SchillingJd
RothR
HeuserJ
2003 Intracellular Bacterial Biofilm-Like Pods In Urinary Tract Infections. Science 301 105 107
24. WrightKj
SeedPc
HultgrenSj
2007 Development Of Intracellular Bacterial Communities Of Uropathogenic Escherichia Coli Depends On Type 1 Pili. Cell Microbiol 9 2230 2241
25. JusticeSs
HungC
TheriotJa
FletcherDa
AndersonGg
2004 Differentiation And Developmental Pathways Of Uropathogenic Escherichia Coli In Urinary Tract Pathogenesis. Proceedings Of The National Academy Of Sciences Of The United States Of America 101 1333 1338
26. ChenSl
HungCs
PinknerJs
WalkerJn
CusumanoCk
2009 Positive Selection Identifies An In Vivo Role For Fimh During Urinary Tract Infection In Addition To Mannose Binding. Proc Natl Acad Sci U S A 106 22439 22444
27. GarofaloCk
HootonTm
MartinSm
StammWe
PalermoJj
2007 Escherichia Coli From Urine Of Female Patients With Urinary Tract Infections Is Competent For Intracellular Bacterial Community Formation. Infection And Immunity 75 52 60
28. RosenDa
HootonTm
StammWe
HumphreyPa
HultgrenSj
2007 Detection Of Intracellular Bacterial Communities In Human Urinary Tract Infection. Plos Med 4 E329
29. RosenDa
PinknerJs
JonesJm
WalkerJn
CleggS
2008 Utilization Of An Intracellular Bacterial Community Pathway In Klebsiella Pneumoniae Urinary Tract Infection And The Effects Of Fimk On Type 1 Pilus Expression. Infect Immun 76 3337 3345
30. SchillingJd
MartinSm
HungCs
LorenzRg
HultgrenSj
2003 Toll-Like Receptor 4 On Stromal And Hematopoietic Cells Mediates Innate Resistance To Uropathogenic Escherichia Coli. Proc Natl Acad Sci U S A 100 4203 4208
31. SongJ
DuncanMj
LiG
ChanC
GradyR
2007 A Novel Tlr4-Mediated Signaling Pathway Leading To Il-6 Responses In Human Bladder Epithelial Cells. Plos Pathog 3 E60
32. Svanborg EdenC
BrilesD
HagbergL
McgheeJ
MichalecS
1984 Genetic Factors In Host Resistance To Urinary Tract Infection. Infection 12 118 123
33. IngersollMa
KlineKa
NielsenHv
HultgrenSj
2008 G-Csf Induction Early In Uropathogenic Escherichia Coli Infection Of The Urinary Tract Modulates Host Immunity. Cell Microbiol 10 2568 2578
34. SivickKe
SchallerMa
SmithSn
MobleyHl
2010 The Innate Immune Response To Uropathogenic Escherichia Coli Involves Il-17a In A Murine Model Of Urinary Tract Infection. J Immunol 184 2065 2075
35. SongJ
BishopBl
LiG
GradyR
StapletonA
2009 Tlr4-Mediated Expulsion Of Bacteria From Infected Bladder Epithelial Cells. Proc Natl Acad Sci U S A 106 14966 14971
36. HedgesS
AndersonP
Lidin-JansonG
De ManP
SvanborgC
1991 Interleukin-6 Response To Deliberate Colonization Of The Human Urinary Tract With Gram-Negative Bacteria. Infect Immun 59 421 427
37. KoYc
MukaidaN
IshiyamaS
TokueA
KawaiT
1993 Elevated Interleukin-8 Levels In The Urine Of Patients With Urinary Tract Infections. Infect Immun 61 1307 1314
38. SchillingJd
MulveyMa
VincentCd
LorenzRg
HultgrenSj
2001 Bacterial Invasion Augments Epithelial Cytokine Responses To Escherichia Coli Through A Lipopolysaccharide-Dependent Mechanism. J Immunol 166 1148 1155
39. LundstedtAc
LeijonhufvudI
RagnarsdottirB
KarpmanD
AnderssonB
2007 Inherited Susceptibility To Acute Pyelonephritis: A Family Study Of Urinary Tract Infection. J Infect Dis 195 1227 1234
40. RagnarsdottirB
SamuelssonM
GustafssonMc
LeijonhufvudI
KarpmanD
2007 Reduced Toll-Like Receptor 4 Expression In Children With Asymptomatic Bacteriuria. J Infect Dis 196 475 484
41. Jones-CarsonJ
BalishE
UehlingDt
1999 Susceptibility Of Immunodeficient Gene-Knockout Mice To Urinary Tract Infection. J Urol 161 338 341
42. MalaviyaR
IkedaT
AbrahamSn
MalaviyaR
2004 Contribution Of Mast Cells To Bacterial Clearance And Their Proliferation During Experimental Cystitis Induced By Type 1 Fimbriated E. Coli. Immunol Lett 91 103 111
43. HaraokaM
HangL
FrendeusB
GodalyG
BurdickM
1999 Neutrophil Recruitment And Resistance To Urinary Tract Infection. J Infect Dis 180 1220 1229
44. DaleyJm
ThomayAa
ConnollyMd
ReichnerJs
AlbinaJe
2008 Use Of Ly6g-Specific Monoclonal Antibody To Deplete Neutrophils In Mice. J Leukoc Biol 83 64 70
45. HopkinsWj
Gendron-FitzpatrickA
BalishE
UehlingDt
1998 Time Course And Host Responses To Escherichia Coli Urinary Tract Infection In Genetically Distinct Mouse Strains. Infect Immun 66 2798 2802
46. SchillingJd
LorenzRg
HultgrenSj
2002 Effect Of Trimethoprim-Sulfamethoxazole On Recurrent Bacteriuria And Bacterial Persistence In Mice Infected With Uropathogenic Escherichia Coli. Infect Immun 70 7042 7049
47. EtoDs
SundsbakJl
MulveyMa
2006 Actin-Gated Intracellular Growth And Resurgence Of Uropathogenic Escherichia Coli. Cell Microbiol 8 704 717
48. MulveyMa
SchillingJd
HultgrenSj
2001 Establishment Of A Persistent Escherichia Coli Reservoir During The Acute Phase Of A Bladder Infection. Infect Immun 69 4572 4579
49. MysorekarIu
HultgrenSj
2006 Mechanisms Of Uropathogenic Escherichia Coli Persistence And Eradication From The Urinary Tract. Proc Natl Acad Sci U S A 103 14170 14175
50. HopkinsW
Gendron-FitzpatrickA
MccarthyDo
HaineJe
UehlingDt
1996 Lipopolysaccharide-Responder And Nonresponder C3h Mouse Strains Are Equally Susceptible To An Induced Escherichia Coli Urinary Tract Infection. Infect Immun 64 1369 1372
51. FerrySa
HolmSe
StenlundH
LundholmR
MonsenTj
2004 The Natural Course Of Uncomplicated Lower Urinary Tract Infection In Women Illustrated By A Randomized Placebo Controlled Study. Scand J Infect Dis 36 296 301
52. MabeckCe
1972 Treatment Of Uncomplicated Urinary Tract Infection In Non-Pregnant Women. Postgrad Med J 48 69 75
53. WatsonJ
RibletR
1974 Genetic Control Of Responses To Bacterial Lipopolysaccharides In Mice. I. Evidence For A Single Gene That Influences Mitogenic And Immunogenic Respones To Lipopolysaccharides. J Exp Med 140 1147 1161
54. AlteriCj
SmithSn
MobleyHl
2009 Fitness Of Escherichia Coli During Urinary Tract Infection Requires Gluconeogenesis And The Tca Cycle. Plos Pathog 5 E1000448
55. ShahinRd
EngbergI
HagbergL
Svanborg EdenC
1987 Neutrophil Recruitment And Bacterial Clearance Correlated With Lps Responsiveness In Local Gram-Negative Infection. J Immunol 138 3475 3480
56. HanssonS
HansonE
HjalmasK
HultengrenM
JodalU
1990 Follicular Cystitis In Girls With Untreated Asymptomatic Or Covert Bacteriuria. Journal Of Urology 143 330 332
57. MarshFp
BanerjeeR
PanchamiaP
1974 The Relationship Between Urinary Infection, Cystoscopic Appearance, And Pathology Of The Bladder In Man. Journal Of Clinical Pathology 27 297 307
58. RhenT
CidlowskiJa
2005 Antiinflammatory Action Of Glucocorticoids–New Mechanisms For Old Drugs. N Engl J Med 353 1711 1723
59. KleinM
PfisterHw
LeibSl
KoedelU
2009 Therapy Of Community-Acquired Acute Bacterial Meningitis: The Clock Is Running. Expert Opin Pharmacother 10 2609 2623
60. MatsukawaM
KumamotoY
HiroseT
MatsuuraA
1994 [Tissue Gamma/Delta T Cells In Experimental Urinary Tract Infection Relationship Between Other Immuno-Competent Cells]. Kansenshogaku Zasshi 68 1498 1511
61. GodalyG
HangL
FrendeusB
SvanborgC
2000 Transepithelial Neutrophil Migration Is Cxcr1 Dependent In Vitro And Is Defective In Il-8 Receptor Knockout Mice. J Immunol 165 5287 5294
62. De ManP
Van KootenC
AardenL
EngbergI
LinderH
1989 Interleukin-6 Induced At Mucosal Surfaces By Gram-Negative Bacterial Infection. Infect Immun 57 3383 3388
63. MysorekarIu
MulveyMa
HultgrenSj
GordonJi
2002 Molecular Regulation Of Urothelial Renewal And Host Defenses During Infection With Uropathogenic Escherichia Coli. J Biol Chem 277 7412 7419
64. WengnerAm
PitchfordSc
FurzeRc
RankinSm
2008 The Coordinated Action Of G-Csf And Elr+Cxc Chemokines In Neutrophil Mobilization During Acute Inflammation. Blood 111 42 49
65. HeldTk
MielkeMe
ChedidM
UngerM
TrautmannM
1998 Granulocyte Colony-Stimulating Factor Worsens The Outcome Of Experimental Klebsiella Pneumoniae Pneumonia Through Direct Interaction With The Bacteria. Blood 91 2525 2535
66. HedgesSr
BjarnadottirM
AgaceW
HangL
SvanborgC
1996 Immunoregulatory Cytokines Modify Escherichia Coli Induced Uroepithelial Cell Il-6 And Il-8 Responses. Cytokine 8 686 697
67. TakatsuK
NakajimaH
2008 Il-5 And Eosinophilia. Curr Opin Immunol 20 288 294
68. CarboneM
HastyDl
YiKc
RueJ
FeraMt
2002 Cytokine Induction In Murine Bladder Tissue By Type 1 Fimbriated Escherichia Coli. Ann N Y Acad Sci 963 332 335
69. RyanPj
WillsonT
AlexanderWs
Di RagoL
MifsudS
2001 The Multi-Organ Origin Of Interleukin-5 In The Mouse. Leukemia 15 1248 1255
70. TotemeyerS
FosterN
KaiserP
MaskellDj
BryantCe
2003 Toll-Like Receptor Expression In C3h/Hen And C3h/Hej Mice During Salmonella Enterica Serovar Typhimurium Infection. Infect Immun 71 6653 6657
71. Bernstein-HanleyI
BalsaraZr
UlmerW
CoersJ
StarnbachMn
2006 Genetic Analysis Of Susceptibility To Chlamydia Trachomatis In Mouse. Genes Immun 7 122 129
72. ChackerianAa
AltJm
PereraTv
DascherCc
BeharSm
2002 Dissemination Of Mycobacterium Tuberculosis Is Influenced By Host Factors And Precedes The Initiation Of T-Cell Immunity. Infect Immun 70 4501 4509
73. CartnerSc
SimeckaJw
LindseyJr
CassellGh
DavisJk
1995 Chronic Respiratory Mycoplasmosis In C3h/Hen And C57bl/6n Mice: Lesion Severity And Antibody Response. Infect Immun 63 4138 4142
74. HopkinsWj
ElkahwajiJ
KendziorskiC
MoserAr
BriggsPm
2009 Quantitative Trait Loci Associated With Susceptibility To Bladder And Kidney Infections Induced By Escherichia Coli In Female C3h/Hej Mice. J Infect Dis 199 355 361
75. HawnTr
ScholesD
LiSs
WangH
YangY
2009 Toll-Like Receptor Polymorphisms And Susceptibility To Urinary Tract Infections In Adult Women. Plos One 4 E5990
76. FerrieresL
HancockV
KlemmP
2007 Biofilm Exclusion Of Uropathogenic Bacteria By Selected Asymptomatic Bacteriuria Escherichia Coli Strains. Microbiology 153 1711 1719
77. SvanborgC
BergstenG
FischerH
GodalyG
GustafssonM
2006 Uropathogenic Escherichia Coli As A Model Of Host-Parasite Interaction. Curr Opin Microbiol 9 33 39
78. WrightKj
SeedPc
HultgrenSj
2005 Uropathogenic Escherichia Coli Flagella Aid In Efficient Urinary Tract Colonization. Infection And Immunity 73 7657 7668
79. HullRa
GillRe
HsuP
MinshewBh
FalkowS
1981 Construction And Expression Of Recombinant Plasmids Encoding Type 1 Or D-Mannose-Resistant Pili From A Urinary Tract Infection Escherichia Coli Isolate. Infect Immun 33 933 938
80. BrewerJa
KhorB
VogtSk
MugliaLm
FujiwaraH
2003 T-Cell Glucocorticoid Receptor Is Required To Suppress Cox-2-Mediated Lethal Immune Activation. Nat Med 9 1318 1322
81. SchrammR
SchaeferT
MengerMd
ThorlaciusH
2002 Acute Mast Cell-Dependent Neutrophil Recruitment In The Skin Is Mediated By Kc And Lfa-1: Inhibitory Mechanisms Of Dexamethasone. J Leukoc Biol 72 1122 1132
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- The Transcription Factor Rbf1 Is the Master Regulator for -Mating Type Controlled Pathogenic Development in
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia